Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jacobs

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|December 2, 2014
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialRanjit Manchanda, Kelly Loggenberg, Saskia Sanderson, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2025
AAV-mediated exon skipping therapy for Usher syndrome, type 2AStephanie A Mauriac, Jiyoon Lee, Jingyuan Zhang, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Global Change Biology|July 31, 2016
Assessing uncertainties in land cover projectionsPeter Alexander, Reinhard Prestele, Peter H Verburg, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Human Mutation|January 19, 2012
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersSusan J Ramus, Antonis C Antoniou, Karoline B Kuchenbaecker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|December 2, 2014
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialRanjit Manchanda, Kelly Loggenberg, Saskia Sanderson, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2025
AAV-mediated exon skipping therapy for Usher syndrome, type 2AStephanie A Mauriac, Jiyoon Lee, Jingyuan Zhang, et al.
Journal of Personalized Medicine|July 29, 2023
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine TrialRebecca Daly, Kate Hetherington, Emily Hazell, et al.
Global Change Biology|July 31, 2016
Assessing uncertainties in land cover projectionsPeter Alexander, Reinhard Prestele, Peter H Verburg, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Human Mutation|January 19, 2012
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriersSusan J Ramus, Antonis C Antoniou, Karoline B Kuchenbaecker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Pageof 12